Clonal Dominance of CD133+ Subset Population as Risk Factor in Tumor Progression and Disease Recurrence of Human Cutaneous Melanoma

International Journal of Oncology - Greece
doi 10.3892/ijo.2012.1590
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Clonal Cytogenetic Progression Within Intratumorally Heterogeneous Meningiomas Predicts Tumor Recurrence

International Journal of Oncology
Cancer ResearchOncology
2011English

Prognostic Risk Factors of First Recurrence in Patients With Primary Stages I-Ii Cutaneous Malignant Melanoma - From the Population-Based Swedish Melanoma Register

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2017English

Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma

PLoS ONE
Multidisciplinary
2013English

Circulating Tumor Cells and Melanoma Progression

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2010English

Gene Variants in Angiogenesis and Lymphangiogenesis and Cutaneous Melanoma Progression

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2013English

Expression of the Soluble Vascular Endothelial Growth Factor Receptor-1 in Cutaneous Melanoma: Role in Tumour Progression

British Journal of Dermatology
DermatologyMedicine
2011English

Erratum To: Progression of Cutaneous Melanoma: Implications for Treatment

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2012English

Risk Factor Reduction in Progression of Angiographic Coronary Artery Disease

Archives of Medical Science
Medicine
2012English

Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy